The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

International Journal of Epidemiology

Volumn 49, Issue 3, 2021, Pages 717-726

  Peeri, Noah C ^a   Shrestha, Nistha ^a   Siddikur Rahman, Md ^b   Zaki, Rafdzah ^c   Tan, Zhengqi ^a   Bibi, Saana ^d   Baghbanzadeh, Mahdi ^e   Aghamohammadi, Nasrin ^c   Zhang, Wenyi ^f   Haque, Ubydul ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b BEGUM ROKEYA UNIVERSITY   (Bangladesh)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d National University of Medical Sciences   (Pakistan)

^e Ofogh Kourosh Chain Stores   (Iran)

^f CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Coronavirus; COVID 19; Epidemic; Epidemiology; MERS; NCoV; Outbreak; SARS

Indexed keywords

ANTIBIOTIC AGENT; BETA1B INTERFERON; CORTICOSTEROID; LOPINAVIR PLUS RITONAVIR; OSELTAMIVIR; REMDESIVIR;

COVID-19; DISEASE PREVALENCE; EPIDEMIC; GLOBAL PERSPECTIVE; GLOBALIZATION; HEALTH RISK; INTERNET; RISK ASSESSMENT; SEVERE ACUTE RESPIRATORY SYNDROME;

AGE; AIRPORT; CARDIOVASCULAR DISEASE; CHINA; CORONAVIRUS DISEASE 2019; COUGHING; DIABETES MELLITUS; EPIDEMIC; GLOBAL HEALTH; HUMAN; HYPERTENSION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY RATE; NONHUMAN; PHYSICIAN; PNEUMONIA; PRIORITY JOURNAL; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEX DIFFERENCE; SNEEZING; VIRUS PNEUMONIA; VIRUS TRANSMISSION; X-RAY COMPUTED TOMOGRAPHY; BETACORONAVIRUS; CORONAVIRINAE; CORONAVIRUS INFECTION; GLOBAL DISEASE BURDEN; PANDEMIC; VIROLOGY;

CHINA; HUBEI; MIDDLE EAST; WUHAN;

CORONAVIRUS;

BETACORONAVIRUS; CHINA; CORONAVIRUS; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 85082122201     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/IJE/DYAA033     Document Type: Review

References (40)

1. Zhu N, Zhang D, Wang W et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020.
2. Gardner L. 2019n-CoV Global Cases. https://gisanddata.maps. arcgis.com/apps/opsdashboard/index.html#/bda7594740fd4029 9423467b48e9ecf6 (2 February 2020, date last accessed).
3. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497-506.
4. Smith RD. Responding to global infectious disease outbreaks: Lessons from SARS on the role of risk perception, communication and management. Soc Sci Med 2006; 63:3113-23.
5. Anderson RM, Fraser C, Ghani AC et al. Epidemiology, transmission dynamics and control of SARS: The 2002-2003 epidemic. Phil Trans R Soc Lond B 2004; 359:1091-105.
6. Amirian ES, Scheurer ME, Zhou R et al. History of chickenpox in glioma risk: A report from the glioma international casecontrol study (GICC). Cancer Med 2016; 5:1352-58.
7. Mackay IM, Arden KE. MERS coronavirus: Diagnostics, epidemiology and transmission. Virol J 2015; 12:222.
8. Al-Omari A, Rabaan AA, Salih S, Al-Tawfiq JA, Memish ZA. MERS coronavirus outbreak: Implications for emerging viral infections. Diagn Microbiol Infect Dis 2019; 93:265-85.
9. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: Epidemiology, characteristics and public health implications. J Hosp Infect 2017; 95:207-13.
10. WHO. MERS-CoV. https://www.who.int/emergencies/merscov/en/(2 February 2020, date last accessed).
11. WHO. Clinical Management of Severe Acute Respiratory Infection when Novel Coronavirus (2019-nCoV) Infection is Suspected. 2020. https://www.who.int/docs/default-source/coro naviruse/clinical-management-of-novel-cov.pdf (2 February 2020, date last accessed).
12. Nassar MS, Bakhrebah MA, Meo SA, Alsuabeyl MS, Zaher WA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Epidemiology, pathogenesis and clinical characteristics. Eur Rev Med Pharmacol Sci 2018; 22:4956-61.
13. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. Lancet Infect Dis 2013; 13:752-61.
14. Arabi YM, Alothman A, Balkhy HH et al.; and the MIRACLE Trial Group. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): Study protocol for a randomized controlled trial. Trials 2018; 19:81.
15. Sheahan TP, Sims AC, Graham RL et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 2017; 9; 396:eaal3653.
16. Sheahan TP, Sims AC, Leist SR et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020; 11:222.
17. Michel A, Waterboer T, Kist M, Pawlita M. Helicobacter pylori multiplex serology. Helicobacter 2009; 14:525-35.
18. Chu CM, Cheng VC, Hung IF et al. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax 2004; 59:252-56.
19. World Health Organization (WHO). Middle East Respiratory Syndrome Coronavirus (MERS-CoV). WHO, 2014.
20. Chan-Yeung M, Xu RH. SARS: Epidemiology. Respirology 2003; 8(Suppl 1):S9-14.
21. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14:523-34.
22. Rivers CM, Majumder MS, Lofgren ET. Risks of death and severe disease in patients with Middle East Respiratory Syndrome Coronavirus, 2012-2015. Am J Epidemiol 2016; 184:460-64.
23. Mizumoto K, Saitoh M, Chowell G, Miyamatsu Y, Nishiura H. Estimating the risk of Middle East Respiratory Syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. Int J Infect Dis 2015; 39:7-9.
24. Leung GM, Hedley AJ, Ho LM et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients. Ann Intern Med 2004; 141:662-73.
25. Rothe C, Schunk M, Sothmann P et al. Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany. N Engl J Med 2020.
26. Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA 2020; E1-E2.
27. Al-Tawfiq JA, Auwaerter PG. Healthcare-associated infections: The hallmark of Middle East respiratory syndrome coronavirus with review of the literature. J Hosp Infect 2019; 101:20-29.
28. Park JE, Jung S, Kim A, Park JE. MERS transmission and risk factors: A systematic review. BMC Public Health 2018; 18:574.
29. Malave A, Elamin EM. Severe Acute Respiratory Syndrome (SARS)-lessons for future pandemics. Virtual Mentor 2010; 12:719-25.
30. Kim K, Andrew SA, Jung K. Public Health Network Structure and Collaboration Effectiveness during the 2015 MERS outbreak in South Korea: An institutional collective action framework. Int J Environ Res Public Health 2017; 14.
31. Wu JT, Leung K. Leung Gm Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet 2020; 1-9.
32. World Health Organization (WHO). Novel Coronavirus 2019. 2020. https://www.who.int/emergencies/diseases/novel-coronavi rus-2019 (2 February 2020, date last accessed).
33. Gardner L. Mapping the Wuhan Coronavirus (2019-nCoV). 2020. https://systems.jhu.edu/(24 January 2020, date last accessed).
34. World Health Organization (WHO). Novel Coronavirus (2019-nCoV) situation reports. 2020. https://www.who.int/emergen cies/diseases/novel-coronavirus-2019/situation-reports (2 February 2020, date last accessed).
35. Elizabeth Cohen C. CDC to Screen at three US Airports for Signs of New Virus from China. 2020. https://edition.cnn.com/2020/01/17/health/wuhan-virus-us-airport-screenings-china-bn/index. html (30 January 2020, date last accessed).
36. Hern_andez JC, Austin Ramzy T. China Confirms New Coronavirus Spreads from Humans to Humans. 2020. https://www.nytimes.com/2020/01/20/world/asia/coronavirus-chinasymptoms. html (24 January 2020, date last accessed).
37. BBC NEWS. New China Virus: Warning against Cover-up as Number of Cases Jumps. 2020. https://www.bbc.com/news/world-asia-china-51185836 (2 February 2020, date last accessed).
38. Centers for Disease Control and Prevention C. 2019 Novel Coronavirus (2019-nCoV), Wuhan, China. 2020. https://www. cdc.gov/coronavirus/2019-nCoV/summary.html (2 February 2020, date last accessed).
39. WORLD Health Organization (WHO). Coronavirus. 2020. https://www.who.int/health-topics/coronavirus (5 February 2020, date last accessed).
40. CDC. CDC Advises Travelers to Avoid All Nonessential Travel to China. https://www.cdc.gov/media/releases/2020/s0128-trav elers-avoid-china.html (2 April 2020, date last accessed).